fig3
Figure 3. TGF-β upregulates PD-L1 expression and inactivates CD8+ cytotoxic lymphocytes, thus resulting in a reduced immune-response to PDAC. PDAC: Pancreatic ductal adenocarcinoma; TGF-β: transforming growth factor-β.
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
